Patent Funded Access to Medicines
Bibliographic Data
| ID | 19516684 |
|---|---|
| Authors | Tom Andreassen (corresponding author) |
| Year | 2015 |
| Volume | 15 |
| Issue | 3 |
| Pages | 152-161 |
| Publication date | 2015-12-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Developing World Bioethics (JOURNAL) |
| Journal identifiers | ISSN: 1471-8731 • E-ISSN: 1471-8847 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/dewb.12058 |
| PMID | 24750573 |
| OpenAlex | W1569978286 |
| Language | EN |
| References cited | 15 |
Instead of impeding access to essential medicines in developing countries, the essay explores why and how patents can serve as a source of funding for the much needed access to medicine. Instead of a weakening of patents, prolonged protection periods are suggested in circumstances where there is widespread lack of access. The revenues from extended patents are seen as a source of funding for drug donations to the least developed countries
Access to medicines · Business · Developing country · Economic growth · Economics · Essential medicines · Geography · International trade · Market access · Public economics · Revenue · Economic Growth and Development · Intellectual Property and Patents · Pharmaceutical Economics and Policy · Finance
| Highly cited | No |
|---|